{{Multiple issues|
{{one source|date=August 2014}}
{{refimprove|date=August 2014}}
}}

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 386256471
| IUPAC_name = 1-Ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid
| image = Rosoxacin.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|rosoxacin}}
| pregnancy_AU =  
| pregnancy_US =  
| legal_UK =  
| legal_US =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 40034-42-2
| ATC_prefix = J01
| ATC_suffix = MB01
| PubChem = 287180
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00817
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 253208
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 3Y1OT3J4NW
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D02305
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 131715
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 291157
<!--Chemical data-->
| C=17 | H=14 | N=2 | O=3
| molecular_weight = 294.30 g/mol
| melting_point = 290
}}

'''Rosoxacin''' (also known as acrosoxacin, tradename Eradacil) is a [[quinolone antibiotic]] indicated for the treatment of urinary tract infections and certain [[sexually transmitted disease]]s. Rosoxacin is not available in the United States.

It was developed by Sanofi-Synthelabo (now part of [[Sanofi-Aventis|sanofi-aventis]]).

It is classified as first generation.<ref name="pmid2173670">{{cite journal |vauthors=Przybilla B, Georgii A, Bergner T, Ring J |title=Demonstration of quinolone phototoxicity ''in vitro'' |journal=[[Dermatologica]] |volume=181 |issue=2 |pages=98â€“103 |year=1990 |pmid=2173670 |doi= 10.1159/000247894|url=}}</ref>

==Synthesis==
[[File:Rosoxacin synthesis.svg|thumb|center|700px|Rosoxacin synthesis:<ref>Y.Lescher and P. M. Carabateas, {{US Patent|3907808}} (1975); Chem. Abstr., 84, 43880p (1975).</ref>]]
The synthesis of rosoxacin begins with a modified [[Hantzsch pyridine synthesis]] employing as component parts [[ammonium acetate]], two equivalents of [[methyl propiolate]], and one of [[3-nitrobenzaldehyde]]. Oxidation of the resulting dihydropyridine ('''2''') with nitric acid followed by saponification, decarboxylation, and reduction of the nitro group with iron and HCl acid gives aniline '''3'''. This undergoes the classic sequence of [[Gould-Jacobs reaction]] with methoxymethylenemalonate ester to form the 4-hydroxyquinoline ring, and then alkylation with [[ethyl iodide]] and saponification of the ester to complete the synthesis of the antibacterial agent rosoxacin ('''4''').

==See also==
*[[Fluoroquinolone]]
*[[Droxacin]]

==References==
{{reflist}}

{{QuinoloneAntiBiotics}}

[[Category:Quinolone antibiotics]]
[[Category:Pyridines]]
[[Category:Carboxylic acids]]


{{antibiotic-stub}}